Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Theratechnologies Inc T.TH

Alternate Symbol(s):  THTX

Theratechnologies Inc. is a Canada-based clinical-stage biopharmaceutical company. The Company is focused on the development and commercialization of therapies addressing unmet medical needs. It markets prescription products for people with human immunodeficiency viruses (HIV) in the United States. The Company's research pipeline focuses on specialized therapies addressing unmet medical needs in HIV, nonalcoholic steatohepatitis (NASH) and oncology. Its medicines include Trogarzo and EGRIFTA SV (tesamorelin for injection). Trogarzo (ibalizumab-uiyk) injection is a long-acting monoclonal antibody which binds to domain 2 of the CD4 T cell receptors. EGRIFTA SV (tesamorelin for injection) is approved in the United States for the reduction of excess abdominal fat in people with HIV who have lipodystrophy. Its portfolio includes Phase I clinical trial of sudocetaxel zendusortide (TH1902), a novel peptide-drug conjugate (PDC), in patients with advanced ovarian cancer.


TSX:TH - Post by User

Comment by Sciotoon May 05, 2021 8:10pm
108 Views
Post# 33137857

RE:RE:RE:As indicated, I voted in favor of all board members

RE:RE:RE:As indicated, I voted in favor of all board members
spceo- I have always respected your tone, thoughtfulness, and analysis. I view you as a leader of this board's braintrust and listened with great interest to your concerns and, frankly, outrage at the BOD and management actions that have devastated shareholder value. Go back and read those posts. These views compelled me to listen and think about how the company, although moving in the right direction, has not been on the right path. Whether you care or not, people respect and listen to you. Now, as we stand at the gate, seeking to send a clear and common message, not only do you walk away from sending a message that the board needs to step up, or choose to at least not vote your shares, you choose to embrace them all. Everyone needs to do what they believe is right, but I encourage you to read your posts from the past several months and see how they align with your decision.
<< Previous
Bullboard Posts
Next >>